US 7820162
Methods for chemically synthesizing immunoglobulin chimeric proteins
granted A61KA61K38/00A61K47/60
Quick answer
US patent 7820162 (Methods for chemically synthesizing immunoglobulin chimeric proteins) held by Syntonix Pharmaceuticals, Inc. expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/642, A61K47/68